Clin2
NCT06664840Possibly a fitNot yet recruiting

MyRareDiet diet tracking tool for inherited metabolic conditions

Urea Cycle DisorderPropionic AciduriaMaple Syrup Urine DiseaseMethylmalonic Acidemia

Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.

This study tests a new diet tracking tool called MyRareDiet designed for people with certain inherited metabolic conditions. It aims to help you track your food and protein intake more easily, which may support your dietary management.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
1 year to 80 years
Study type
Interventional

Who can take part

  • You have been diagnosed with a urea cycle disorder, propionic acidemia, maple syrup urine disease, or methylmalonic acidemia.
  • You get at least half of your daily energy from food you eat by mouth.
  • You know (or have been prescribed) your daily energy goal and your protein limit.
  • You have an internet-connected device (like a smartphone or tablet) to access the MyRareDiet app.
  • You are not pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04602325Recruiting
Blood and brain injury biomarker study for inherited metabolic disorders

This trial studies blood and other measurable signs (biomarkers) that may reflect brain injury after certain inherited metabolic conditions. Results may help doctors better detect and understand brain effects from these illnesses, especially episodes that affect the brain.

Washington D.C., District of Columbia
NCT06953505Recruiting
At-home ammonia monitoring for inherited metabolic disorders

This trial tests a device for measuring ammonia levels at home in people with rare metabolic conditions that cause high ammonia. It aims to make monitoring easier and more convenient for patients.

Portland, Oregon
NCT06360913Recruiting
Blood and urine test for rare metabolic diseases

This study uses a simple blood spot and urine test to look for chemical signs of rare metabolic diseases. It aims to improve early detection and understanding of these conditions across all ages, including healthy individuals.

Brussels
NCT06092346Recruiting
Understanding rare purine and pyrimidine metabolism disorders

This study aims to learn more about rare disorders of purine and pyrimidine metabolism (DPPM), which can affect the brain, immune system, kidneys, and muscles. Researchers will study people with these disorders, their family members, and healthy volunteers to better understand the condition over time.

Bethesda, Maryland
NCT07704606Not yet recruiting
Metabolite testing in blood and breath for metabolic conditions

This study looks at chemicals in blood and breath to better understand metabolic conditions like epilepsy treated with a special diet, urea cycle disorders, and other inherited metabolic diseases. It may help improve diagnosis and monitoring.

NCT06729554Recruiting
Education and support program for rare disease kids

This study tests a targeted educational and support program for children and teens with rare diseases. It helps families learn more about the condition and cope better with day-to-day challenges.

Graz, Austria

Hear when a new Maple Syrup Urine Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.